Acme United (ACU) Net Income towards Common Stockholders (2010 - 2026)
Acme United's (ACU) quarterly Net Income towards Common Stockholders came in at $5.1 million in Q2 2026, up 6.29% year-over-year from $4.8 million in Q2 2025, and up 412.79% quarter-over-quarter from $985000.0 in Q1 2026.
Analysis
Acme United (ACU) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Acme United has disclosed Net Income towards Common Stockholders across 16 years of filings, most recently posting $5.1 million for Q2 2026.
- In Q2 2026, Net Income towards Common Stockholders rose 6.29% year-over-year to $5.1 million; the TTM figure through Jun 2026 stood at $9.8 million (down 2.6% YoY), while the FY2025 annual figure was $10.2 million, up 4.34% from the prior year.
- Net Income towards Common Stockholders came in at $5.1 million for Q2 2026 at Acme United, up from $985000.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $11.2 million in Q4 2023 to a low of -$749704.0 in Q4 2022.
- Average Net Income towards Common Stockholders over 5 years is $2.6 million, with a median of $1.9 million recorded in 2025.
- Year-over-year, Net Income towards Common Stockholders slumped 179.99% in 2022 and surged 3262.5% in 2023.
- Over 5 years, Net Income towards Common Stockholders stood at -$749704.0 in 2022, then soared by 1594.88% to $11.2 million in 2023, then slumped by 87.1% to $1.4 million in 2024, then gained by 29.75% to $1.9 million in 2025, then surged by 169.18% to $5.1 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $5.1 million in Q2 2026, $985000.0 in Q1 2026, and $1.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 378.00 Mn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 139.00 Mn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 147.90 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 126.00 Mn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 26.69 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 5.05 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | -1.30 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 2.77 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | -217,306.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.05 Mn |
| Mar 31, 2026 | 985,000.00 |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 4.75 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 4.45 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | 11.21 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 3.44 Mn |
| Mar 31, 2023 | 990,000.00 |
| Dec 31, 2022 | -749,704.00 |
| Sep 30, 2022 | 64,000.00 |
| Jun 30, 2022 | 2.74 Mn |
| Mar 31, 2022 | 830,000.00 |
| Dec 31, 2021 | 937,302.00 |
| Sep 30, 2021 | 2.05 Mn |